Rhode Island Patent of the Month – March 2024
EpiVax, Inc., an immunology technology company, is developing treatment regimes with regulatory t-cell epitopes to target immune-related disorders. Their innovative approach involves inducing regulatory T-cells to suppress immune responses in patients, offering new hope for conditions such as autoimmune diseases, allergies, and transplant-related disorders.
At the heart of this method lies a novel class of regulatory T-cell epitopes, referred to as “Tregitopes.” These Tregitopes, comprised of specific amino acid sequences, have shown remarkable efficacy in modulating the immune system’s response. By administering therapeutically effective amounts of Tregitope compositions to patients, EpiVax aims to harness the power of regulatory T-cells to dampen unwanted immune reactions.
The beauty of this approach lies in its specificity and precision. Unlike broad-based immune-depleting therapies that weaken the entire immune system, EpiVax’s method targets the underlying mechanisms of immune regulation, offering a more targeted and effective treatment option. This precision is crucial for minimizing side effects and maximizing therapeutic benefits.
The potential applications of EpiVax’s method are vast. From autoimmune diseases like type 1 diabetes and lupus to transplant-related disorders such as graft-versus-host disease, the ability to induce immune tolerance could transform the lives of millions of patients worldwide. Additionally, this method holds promise for mitigating allergic reactions, preventing immune rejection of biologic medicines, and combating immune responses to infectious diseases.
Central to EpiVax’s approach is the identification and utilization of regulatory T-cell epitopes contained within common proteins. These Tregitopes, carefully selected for their ability to activate regulatory T-cells, serve as the cornerstone of the therapeutic compositions developed by EpiVax. By leveraging these natural mechanisms of immune regulation, EpiVax aims to provide safer and more effective treatments for a wide range of immune-related disorders.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
